Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Structure of Lacticaseicin 30 and Its Engineered Variants Revealed an Interplay between the N-Terminal and C-Terminal Regions in the Activity against Gram-Negative Bacteria.
Pharmaceutics. 2022 Sep 12;14(9):1921. doi: 10.3390/pharmaceutics14091921.
Pharmaceutics. 2022.
PMID: 36145669
Free PMC article.
Expression of five class II bacteriocins with activity against Escherichia coli in Lacticaseibacillus paracasei CNCM I-5369, and in a heterologous host.
Madi-Moussa D, Coucheney F, Drider D.
Madi-Moussa D, et al.
Biotechnol Rep (Amst). 2021 May 25;30:e00632. doi: 10.1016/j.btre.2021.e00632. eCollection 2021 Jun.
Biotechnol Rep (Amst). 2021.
PMID: 34136365
Free PMC article.
Item in Clipboard
Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins.
Pérez-Ramos A, Madi-Moussa D, Coucheney F, Drider D.
Pérez-Ramos A, et al. Among authors: madi moussa d.
Microorganisms. 2021 Oct 7;9(10):2107. doi: 10.3390/microorganisms9102107.
Microorganisms. 2021.
PMID: 34683428
Free PMC article.
Review.
Item in Clipboard
Lacticaseicin 30 and Colistin as a Promising Antibiotic Formulation against Gram-Negative β-Lactamase-Producing Strains and Colistin-Resistant Strains.
Madi-Moussa D, Belguesmia Y, Charlet A, Drider D, Coucheney F.
Madi-Moussa D, et al.
Antibiotics (Basel). 2021 Dec 24;11(1):20. doi: 10.3390/antibiotics11010020.
Antibiotics (Basel). 2021.
PMID: 35052897
Free PMC article.
Item in Clipboard
Cite
Cite